Profile for Tetraphase Pharmaceuticals Inc. (TTPH)

$ 2.53   -0.05 (-1.94%) Volume: 40.5k 3:59 PM EDT 8-Jul-2020
After Hours:  $ 2.65   0.12 (+4.74%) Volume: 110 5:54 PM EDT 8-Jul-2020
Business Description:
Tetraphase Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It creates novel antibiotics for serious and life-threatening multidrug-resistant infections. Its pipeline products are ERAVACYCLINE, TP-271, and TP-6076.
Address: 480 Arsenal Way, Suite 100, Watertown, MA, USA, 02472
Telephone: +1 617 715-3600 Website: http://www.tphase.com
Facsimile: +1 617 926-3557 Email: N/A
Details
CEO: Larry Edwards
Employees: 67 Market Cap: 18.48m
Issue Type: CS
Auditor: Ernst & Young LLP
Last Audit: Unqualified Opinion with Explanation
Indices: N/A
Industry Classifications
Sector: Healthcare CIK: 1373707
Industry: Biotechnology
Sub-Industry:    Biotechnology
NAICS: Pharmaceutical Preparation Manufacturing (325412)
SIC: Pharmaceutical Preparations (2834)